Reneuron Group (RENE)

 

Latest News

Block Listing Review and Total Voting Rights

RNS Number: 1143Y ReNeuron Group plc 01 March 2017 1 March 2017 AIM: RENE ReNeuron Group plc ("ReNeuron" or "the Company") Block Listing Review and Total Voting Rights ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, provides the following update in accordance with Schedule Six of the AI...

ReNeuron featured in BBC documentary

RNS Number: 9216W ReNeuron Group plc 15 February 2017 15 February 2017 AIM: RENE RNS REACH ReNeuron Group plc ("ReNeuron" or the "Company") ReNeuron featured in BBC documentary "Andrew Marr: My Brain and Me" ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, announces that its...

Director Deals - ReNeuron Group PLC (RENE)

Michael Hunt, Financial Director, bought 250,000 shares in the company on the 7th February 2017 at a price of 2.64p. The D...

Director Share Purchase

RNS Number: 2499W ReNeuron Group plc 07 February 2017 7 February 2017 AIM: RENE ReNeuron Group plc ("ReNeuron" or the "Company") Director Share Purchase ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, was informed on 7 February 2017 that, on the same day, Michael Hunt , the Company...

All News

DateHeadlineSource
01-03-17Block Listing Review and Total Voting RightsRNS
15-02-17ReNeuron featured in BBC documentaryRNS
07-02-17Director Deals - ReNeuron Group PLC (RENE)StockMarketWire
07-02-17Director Share PurchaseRNS
01-02-17ReNeuron Group to present at the Shares Spotlight Evening in Edinburgh on 15 February 2017StockMarketWire
14-12-16Director Share PurchaseRNS
05-12-16ReNeuron widens H1 pretax lossStockMarketWire
05-12-16ReNeuron reports positive results in Phase II Stroke TrialStockMarketWire
05-12-16Interim ResultsRNS
05-12-16Reports Positive Results in Phase II Stroke TrialRNS
14-11-16Notification of Interim ResultsRNS
14-10-16ReNeuron Group Plc to present at the Shares Investor Evening in London on 27th October 2016StockMarketWire
05-10-16Notification of Major Interest in SharesRNS
22-09-16Block Listing Review and Total Voting RightsRNS
06-09-16ReNeuron passes AGM resolutionsStockMarketWire
06-09-16Result of AGMRNS
06-09-16AGM Trading UpdateRNS
05-08-16Posting of Annual Report and Notice of AGMRNS
04-08-16Stroke clinical data published in The LancetRNS
22-07-16Publication of positive pre-clinical retinal dataRNS
20-07-16Directors' Interest in Shares and Share OptionsRNS
07-07-16Preliminary ResultsRNS
14-06-16Notification of Preliminary ResultsRNS
13-06-16Reuron says patient recruitment completed in stroke trial StockMarketWire
13-06-16Patient recruitment completed in stroke trialRNS
09-06-16ReNeuron pursues brain cancer with exosome platform StockMarketWire
09-06-16Pursues brain cancer with exosome platformRNS
08-06-16ReNeuron Group gives Retinitis pigmentosa update StockMarketWire
08-06-16Retinitis pigmentosa update & Notice of KOL eventRNS
31-05-16Change of AdviserRNS
21-03-16Are Today’s Double-Digit Rises Just The Start For Filtronic Plc, Angle plc And ReNeuron Group Plc?Motley Fool
15-03-16RENE says first patient treated in RP clinical trial StockMarketWire
15-03-16First Patient Treated in RP Clinical TrialRNS
23-02-16ReNeuron Relocates to South WalesRNS
17-02-16Director Deals - ReNeuron Group PLC (RENE)StockMarketWire
17-02-16Director Deals - ReNeuron Group PLC (RENE)StockMarketWire
17-02-16Director Deals - ReNeuron Group PLC (RENE)StockMarketWire
17-02-16Director's DealingsRNS
03-02-16Director Share PurchaseRNS
01-02-16ReNeuron granted key US patentStockMarketWire

RSS feeds

  • Editorial news feed for LSE:RENE Editorial
  • Regulatory news feed for LSE:RENE Regulatory